Madrigal Pharmaceuticals
MDGL
MDGL
91 hedge funds and large institutions have $471M invested in Madrigal Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
15.11% more ownership
Funds ownership: 21.39% → 36.5% (+15%)
Holders
91
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$51.2M | |
| 2 | +$35M | |
| 3 | +$18.7M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$17.3M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
+$16.5M |
Top Sellers
| 1 | -$14M | |
| 2 | -$4.5M | |
| 3 | -$4.45M | |
| 4 |
Renaissance Technologies
New York
|
-$3.64M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.64M |